The Technical Analyst
Select Language :
Assembly Biosciences Inc [ASMB]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Assembly Biosciences Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Assembly Biosciences Inc is listed at the  Exchange

-0.60% $13.30

America/New_York / 28 mar 2024 @ 16:00


Assembly Biosciences Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 72.92 mill
EPS: -17.16
P/E: -0.780
Earnings Date: Mar 27, 2024
SharesOutstanding: 5.48 mill
Avg Daily Volume: 0.0297 mill
RATING 2024-03-28
B-
Sell
RATINGS
Rating CashFlow: Neutral
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Sell
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.780 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.13x
Company: PE -0.780 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$1.011
(-92.40%) $-12.29
Date: 2024-03-28
Expected Trading Range (DAY)

$ 12.43 - 14.07

( +/- 6.17%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-13 Cook Robert Donald Ii Buy 0
2024-01-18 Schornstein Alexander Buy 345 086 Common Stock
2024-01-17 Schornstein Alexander Buy 299 994 Common Stock
2023-12-07 Cihlar Tomas Buy 0
2023-11-21 Schornstein Alexander Buy 100 000 Common Stock
INSIDER POWER
64.64
Last 95 transactions
Buy: 4 317 018 | Sell: 737 887

Forecast: 16:00 - $13.27

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $13.27
Forecast 2: 16:00 - $13.27
Forecast 3: 16:00 - $13.27
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $13.30 (-0.60% )
Volume 0.0301 mill
Avg. Vol. 0.0297 mill
% of Avg. Vol 101.28 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Assembly Biosciences Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Assembly Biosciences Inc

RSI

Intraday RSI14 chart for Assembly Biosciences Inc

Last 10 Buy & Sell Signals For ASMB

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Assembly Biosciences Inc

ASMB

Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical trials for the treatment of HBV. The company has collaboration agreements with BeiGene, Ltd. and Arbutus Biopharma Corporation; and Antios Therapeutics, Inc. to evaluate a triple combination treatment in patients with chronic hepatitis B virus infection. It also has strategic license agreements with Indiana University Research and Technology Corporation; and Door Pharmaceuticals, LLC. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.

Last 10 Buy Signals

Date Signal @
OKBUSDMar 28 - 20:07$63.80
SNXUSDMar 28 - 20:05$5.02
GLMRUSDMar 28 - 20:030.508
XAUTUSDMar 28 - 20:02$2 229.60
SBDUSDMar 28 - 20:02$4.77
GTCUSDMar 28 - 20:032.15
ETHWUSDMar 28 - 20:034.34
SEIUSDMar 28 - 20:020.862
STORJUSDMar 28 - 20:02$0.829
GALAUSDMar 28 - 20:02$0.0676

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.